Pfizer Consumer Healthcare acquired by GlaxoSmithKline (GSK-Pfizer consumer joint venture)
GlaxoSmithKline (GSK-Pfizer consumer joint venture) acquired Pfizer Consumer Healthcare, an United States & Global supplements brand, on Aug 1, 2019.
Transaction summary
- Target
- Pfizer Consumer Healthcare
- Announced
- 2018-12-19
- Geography
- United States & Global
- Type
- Acquisition
- Deal type
- Control
- Stake acquired
- 68%
- First added
- 2026-10-31
- Latest update
- 2026-10-31
Value and multiples
100% enterprise value
Undisclosed
Value not disclosed
Basis: FundComb estimate
Reported price is assumed to be 100% EV unless stated otherwise. Partial-stake estimates are qualified in the basis notes.
EV / revenue
-
Period: FY2017
Basis: Public source
EV / EBITDA
-
EBITDA basis not stated
Basis: Public source
Basis
- The price was not disclosed. Revenue: US$3.47bn (FY2017). Pfizer contributed its consumer health business for 32% of a joint venture controlled by GSK; no transaction value was disclosed.
Source summary
GlaxoSmithKline plc and Pfizer Inc to form new world-leading Consumer Healthcare Joint Venture
EstimatedCombined 2017 global sales for the Joint Venture were approximately £9.8 billion ($12.7 billion)
Open sourceContinue your research
Related transaction comps
Vitabiotics acquired by Bain Capital
2026-07-24 · Confirmed
View transaction → consumer healthOpella acquired by Clayton, Dubilier & Rice
2024-10-21 · Confirmed
View transaction → consumer healthOnnit Labs, Inc. acquired by Unilever
2021-04-26 · Estimated
View transaction → consumer healthSmartyPants Vitamins acquired by Unilever
2020-11-25 · Estimated
View transaction →